Spearhead Capital Advisors, LLC Seagen Inc. Transaction History

Spearhead Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$119.61 - $157.85 $543,866 - $717,743	-4,547 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$142.57 - $190.86 $6,273 - $8,397	44 Added 0.98%	4,547 $703,000
Q3 2021 Oct 27, 2021	BUY	$142.45 - $169.82 $6,125 - $7,302	43 Added 0.96%	4,503 $765,000
Q2 2021 Aug 10, 2021	BUY	$135.08 - $161.1 $53,221 - $63,473	394 Added 9.69%	4,460 $704,000
Q1 2021 Apr 28, 2021	BUY	$137.51 - $190.8 $55,829 - $77,464	406 Added 11.09%	4,066 $565,000

Q4 2020 Feb 02, 2021	BUY	$164.63 - $211.93 $602,545 - $775,663	3,660 New	3,660 $641,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.